MedPath

Effect of Cinnamon on the treatment of Multiple Sclerosis

Not Applicable
Conditions
Multiple sclerosis.
Multiple sclerosis
Registration Number
IRCT2016072529041N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with Multiple Sclerosis, non-allergic or intolerance to Cinnamon, no alcohol, absence of pregnancy or lactation, absence of hormone therapy and absence of any liver dysfunction , kidney failure, gout and rheumatoid arthritis , breast fibroids , breast cancer and avoiding the use of statins.
Exclusion criteria : Change medication , especially anti-inflammatory drugs during the study and Failure to follow study protocol.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Interleukin- 6. Timepoint: Before intervention, two months after intervention. Method of measurement: Serum concentration of IL-6.;Hs-CRP. Timepoint: Before intervention, two months after intervention. Method of measurement: Serum concentration of hs-CRP.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath